CKD Bio Corp. | Income Statement
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
100,371
106,390
106,691
113,013
118,187
124,510
Cost of Goods Sold (COGS) incl. D&A
86,204
97,818
86,788
87,355
94,063
102,229
Gross Income
14,166
8,572
19,902
25,658
24,124
22,281
SG&A Expense
12,218
11,213
11,860
14,042
15,091
15,272
EBIT
1,949
2,641
8,042
11,616
8,824
7,009
Unusual Expense
-
-
-
487
11
628
Non Operating Income/Expense
311
779
278
585
247
1,564
Interest Expense
722
340
175
155
156
129
Pretax Income
1,903
1,939
8,103
12,112
9,641
9,295
Income Tax
246
834
1,450
2,678
1,625
1,339
Consolidated Net Income
1,657
1,105
6,653
9,435
8,016
7,956
Net Income
1,657
1,105
6,653
9,435
8,016
7,956
Net Income After Extraordinaries
1,657
1,105
6,653
9,435
8,016
7,956
Net Income Available to Common
1,657
1,105
6,653
9,435
8,016
7,956
EPS (Basic)
323.00
215.00
1,297.00
1,839.00
1,563.00
1,551.08
Basic Shares Outstanding
5
5
5
5
5
5
EPS (Diluted)
323.12
215.43
1,297.04
1,839.30
1,562.79
1,551.08
Diluted Shares Outstanding
5
5
5
5
5
5
EBITDA
13,661
8,775
18,947
20,612
17,892
15,965
Other Operating Expense
-
-
-
-
209
-
Non-Operating Interest Income
365
263
269
148
214
223
About CKD Bio
View Profile
